NA
SYNH

Navellier & Associates’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Navellier & Associates’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-11,327
Closed -$432K – 319
2016
Q2 		$432K Sell
11,327
-4,738
-29% -$208K 0.06% 149
2016
Q1 		$662K Buy
16,065
+9,350
+139% +$385K 0.09% 111
2015
Q4 		$326K Buy
+6,715
New +$299K 0.04% 163

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Navellier & Associates's SYNH Position: Q3 2016 in Review

Navellier & Associates sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2016, closing a stake of 11,327 shares — an estimated $432K sold.

Navellier & Associates first reported a position in SYNH in Q4 2015 and held it in 3 quarters. The position peaked at $662K in Q1 2016. 237 funds tracked by Wall St. Rank hold SYNH as of Q3 2016.

  • Navellier & Associates reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2016 after selling out during the quarter.
  • Navellier & Associates sold 11,327 Syneos Health, Inc. Class A Common Stock shares in Q3 2016, an estimated $432K.
  • Navellier & Associates first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 3 quarters.
  • Navellier & Associates's Syneos Health, Inc. Class A Common Stock position peaked at $662K in Q1 2016.
  • 237 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2016.

Based on Navellier & Associates's 13F filing for Q3 2016, filed 24 Oct 2016.